US
Coriolis Pharma opens new US headquarter and laboratory
March 16, 2026Manufacturing and Production Coriolis Pharma, US, development
Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for Advanced Technologies (ACAT) in North …
Abselion establishes a US subsidiary in MassachusettsÂ
March 10, 2026Research and Development Abselion, The Engine, US
Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. The company aims to strengthen …
ESTEVE CDMO commences $15.5m expansion of US facility
March 6, 2026Manufacturing and Production ESTEVE, US, expansion
ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, …
Sharp invests $100m in US and EU manufacturing and packaging facilities
October 27, 2025Manufacturing and Production EU, Sharp Services, US, manufacturing and packaging
Sharp Services, a pharmaceutical packaging and sterile manufacturing specialist, has announced investments totalling $100m across its US and European facility …
Moderna doses first US patient in phase 1 trial of mRNA-4106 for solid tumours
May 23, 2025Research and Development Moderna, Oncology, START Center for Cancer Research, US
The START Center for Cancer Research has dosed the first US participant in Moderna’s phase 1 clinical trial evaluating mRNA-4106, …
Strategic alliance announced between Recipharm and Exela
October 1, 2024Research and Development Corporate, Exela, Recipharm, US
Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …
Amgen opens new biomanufacturing facility in Ohio, US
February 27, 2024Manufacturing and Production Amgen, Biomanufacturing, Manufacturing Facility, Ohio, Pharmacy, US
Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. This will be the latest …
Expansion for first FDA-approved video game for ADHD treatment
July 23, 2021Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology
Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
New warning added to J&J vaccine in US
July 13, 2021Manufacturing and Production COVID-19, FDA, J&J, JJ, US, Vaccine
The FDA has made the decision to add a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine, …
CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab
June 29, 2021Manufacturing and Production CHMP, EMA, EU, FDA, US
Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive …
New test proven to detect over 50 types of cancer
June 25, 2021Medical Communications Cancer. test, US, oncology
Final results from a study into a new blood test that can detect more than 50 types of cancer have …
G7: UK to donate 100 million surplus vaccine doses
June 11, 2021Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine
Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
Profits over patients: US pharma spending billions on investor payouts
June 2, 2021Research and Development Trump, US, stocks
In 2017 Donald Trump signed the Tax Cuts and Jobs Act (TCJA), creating billions of dollars in tax rate cuts …
US Department of Defense selects Faron for $6.1m COVID-19 research funding
January 18, 2021Sales and Marketing Faron Pharmaceuticals, US
The US Department of Defense (DoD) has selected Faron Pharmaceuticals’ HIBISCUS study to receive $6.1 million of funding from the …
Moderna’s COVID-19 vaccine receives emergency approval from FDA
December 21, 2020Sales and Marketing COVID-19, FDA, Moderna, US, Vaccine
Moderna has announced that the FDA yesterday authorised the emergency use of mRNA-1273, the biotechnology company’s vaccine against COVID-19 in …
Latest content
FibroFind appoints Lee Borthwick as CEO
